SCHEMBL1726348

SCHEMBL1726348

COC(=O)c1cncs1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL27643705 0.98 KMT2A (0.47)
SCHEMBL23293397 0.80 KMT2A (0.40)
SCHEMBL21484937 0.80 CDC7 (0.39)
SCHEMBL28164379 0.79
SCHEMBL2650842 0.79
SCHEMBL6368963 0.79 ALDH1A1 (0.42)
SCHEMBL28296615 0.79 KMT2A (0.41)
SCHEMBL290564 0.79 CDC7 (0.49)
SCHEMBL5140577 0.79 KMT2A (0.51)
Methyl Alcohol SCHEMBL28357518 0.78 KMT2A (0.43)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 189 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110483440-A A kind of preparation method of 2- (the bromo- 1,3- thiazole -5- base of 2-) acetonitrile SHANGHAI RAISE CHEMICAL TECH CO LTD 2019-11-22 CN claimed
US-10224485-B2 Process for preparing a crystalline organic semiconductor material BASF SE (DE) 2019-03-05 US claimed
CN-106632134-A 2-(4-thiazolinone-2-imino)thiazole-5-carboxylate and preparation method and application thereof 湖南大学 2017-05-10 CN claimed
US-20170012208-A1 ORGANIC SEMICONDUCTOR FORMULATIONS USINVEST LLC 2017-01-12 US claimed
CN-1185219-C Trans olefinic glucokinase activators HOFFMANN LA ROCHE (CH) 2005-01-19 CN claimed
CN-1411453-A Trans olefinic glucokinase activators HOFFMANN LA ROCHE (CH) 2003-04-16 CN claimed
WO-2026103337-A1 NOVEL SUBSTITUTED HETEROCYCLIC COMPOUND AS APELIN RECEPTOR MODULATOR 德睿智药(苏州)新药研发有限公司 2026-05-21 WO disclosed
EP-4665733-A1 AMINO-SUBSTITUTED PYRROLOTRIAZINE DERIVATIVES AS INHIBITORS OF SGK1 Bristol-Myers Squibb Company (US) 2025-12-24 EP disclosed
CN-113072546-B Five-membered heteroaromatic derivative and preparation method and application thereof 广东东阳光药业股份有限公司 2025-05-30 CN disclosed
CN-119684317-A Macrocyclic compound and application thereof 郑州德迈药业有限公司 2025-03-25 CN disclosed
WO-2024173323-A1 AMINO-SUBSTITUTED PYRROLOTRIAZINE DERIVATIVES AS INHIBITORS OF SGK1 BRISTOL-MYERS SQUIBB COMPANY (US) 2024-08-22 WO disclosed
CN-118451078-A Modified proteins and protein degrading agents 上海睿跃生物科技有限公司 2024-08-06 CN disclosed
CN-112867712-B Carboxamide as ubiquitin-specific protease inhibitor 瓦洛早期发现股份有限公司 2024-07-16 CN disclosed
EP-0715618-A1 HYDROXYETHYLAMINO SULPHONAMIDES USEFUL AS RETROVIRAL PROTEASE INHIBITORS G.D. SEARLE & CO. (US) 1996-06-12 EP disclosed
WO-1995006030-A1 HYDROXYETHYLAMINO SULPHONAMIDES USEFUL AS RETROVIRAL PROTEASE INHIBITORS G.D. SEARLE & CO. (US) 1995-03-02 WO disclosed
EP-0296673-B1 Thiazole derivatives SHELL INT RESEARCH (NL) 1994-03-09 EP disclosed
CN-1022015-C Bactericidal composition containing thiazole derivative SHELL INT RESEARCH (NL) 1993-09-08 CN disclosed
US-4877802-A FUNGICIDES SHELL INTERNATIONALE RESEARCH MAATSCHAPPIJ B.V. (NL) 1989-10-31 US disclosed
CN-1033626-A Thiazole derivative SHELL INT RESEARCH (NL) 1989-07-05 CN disclosed
EP-0296673-A1 Thiazole derivatives SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) 1988-12-28 EP disclosed